Sophie Wildsmith

Executive Director, Head of Immuno-oncology Precision Diagnostics Development @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2023 — Present

Executive Director, Head of Immuno-oncology Precision Diagnostics Development @AstraZeneca

View department →

Cambridge, GB

Leads a global cross-functional team to deliver world-class diagnostics for AZ immunotherapiesalso Diagnostics Tumour Area Lead for Head and Neck Cancer (April 2024-present)

EDUCATION

2002 — 2004

Cranfield School of Management

Executive MBA, management

1990 — 1994

UCL

PhD, Biochemical Engineering

1986 — 1990

Nottingham Trent University

Bachelor of Science (BSc), Applied Biology (Biotechnology)

SKILLS

EntrepreneurshipBiotechnologyStrategyLife SciencesPcrPatent ApplicationsOncologyDue DiligenceBusiness StrategyLifesciencesMolecular BiologyPharmaceutical IndustryBiomarkersClinical DevelopmentGenomicsDrug DiscoveryDrug DevelopmentBiopharmaceuticalsClinical TrialsCompanion DiagnosticsPersonalised Healthcare

ABOUT SOPHIE WILDSMITH

Over 30 years experience in pharma/ biotech in both scientific and business leadership roles-Applies diverse experience to identify opportunities and provide solutions-Motivated by future possibilities, interesting challenges and helping others.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Sophie Wildsmith — Executive Director, Head of Immuno-oncology Precision Diagnostics Development at AstraZeneca in Cambridge, GB | Unifers